Organization
Tenet Medicines
2 clinical trials
Clinical trial
A Phase 1b/2a Study of VB119 in Adult Subjects With Primary Membranous NephropathyStatus: Active (not recruiting), Estimated PCD: 2023-11-21
Clinical trial
A Phase 2 Study of VB119 in Adult Subjects With Steroid-Sensitive Primary Minimal Change Disease (MCD) or Primary Focal Segmental Glomerulosclerosis (FSGS)Status: Terminated, Estimated PCD: 2023-05-03